Q8BGT5
Gene name |
Gpt2 (Aat2) |
Protein name |
Alanine aminotransferase 2 |
Names |
ALT2, Glutamate pyruvate transaminase 2, GPT 2, Glutamic--alanine transaminase 2, Glutamic--pyruvic transaminase 2 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:108682 |
EC number |
2.6.1.2: Transaminases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8BGT5
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8BGT5-F1 | Predicted | AlphaFoldDB |
25 variants for Q8BGT5
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3398909303 | 36 | K>M | No | EVA | |
| rs3399431930 | 42 | S>R | No | EVA | |
| rs3388967523 | 91 | I>N | No | EVA | |
| rs3389003178 | 118 | Y>N | No | EVA | |
| rs3388994866 | 150 | Y>H | No | EVA | |
| rs3388995950 | 214 | Q>R | No | EVA | |
| rs3388994707 | 269 | G>R | No | EVA | |
| rs3388994622 | 274 | Q>K | No | EVA | |
| rs3388994672 | 289 | W>R | No | EVA | |
| rs3388995946 | 290 | E>G | No | EVA | |
| rs3388985291 | 329 | N>D | No | EVA | |
| rs3388997939 | 342 | Y>C | No | EVA | |
| rs3389003129 | 345 | E>K | No | EVA | |
| rs3388994871 | 346 | C>S | No | EVA | |
| rs3388998512 | 351 | G>S | No | EVA | |
| rs3389002290 | 367 | V>L | No | EVA | |
| rs3388991478 | 406 | E>V | No | EVA | |
| rs3388967493 | 417 | K>Q | No | EVA | |
| rs3389003177 | 434 | L>V | No | EVA | |
| rs3388967518 | 464 | F>S | No | EVA | |
| rs3399379301 | 467 | M>I | No | EVA | |
| rs3388994841 | 480 | G>D | No | EVA | |
| rs3388973896 | 489 | T>S | No | EVA | |
| rs3388998438 | 500 | V>M | No | EVA | |
| rs219981505 | 501 | D>E | No | EVA |
No associated diseases with Q8BGT5
1 regional properties for Q8BGT5
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Aminotransferase, class I/classII | 112 - 499 | IPR004839 |
Functions
| Description | ||
|---|---|---|
| EC Number | 2.6.1.2 | Transaminases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| L-alanine:2-oxoglutarate aminotransferase activity | Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate. |
| pyridoxal phosphate binding | Binding to pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| 2-oxoglutarate metabolic process | The chemical reactions and pathways involving oxoglutarate, the dianion of 2-oxoglutaric acid. It is a key constituent of the TCA cycle and a key intermediate in amino-acid metabolism. |
| biosynthetic process | The chemical reactions and pathways resulting in the formation of substances; typically the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones. |
| L-alanine catabolic process | The chemical reactions and pathways resulting in the breakdown of L-alanine, the L-enantiomer of 2-aminopropanoic acid, i.e. (2S)-2-aminopropanoic acid. |
| L-alanine metabolic process | The chemical reactions and pathways involving L-alanine, the L-enantiomer of 2-aminopropanoic acid, i.e. (2S)-2-aminopropanoic acid. |
| positive regulation of gluconeogenesis | Any process that activates or increases the frequency, rate or extent of gluconeogenesis. |
3 homologous proteins in AiPD
| 10 | 20 | 30 | 40 | 50 | 60 |
| MQRAAVLVRR | GSCPRASGPW | GRSHSSAAAE | ASAALKVRPE | RSPRDRILTL | ESMNPQVKAV |
| 70 | 80 | 90 | 100 | 110 | 120 |
| EYAVRGPIVL | KAGEIEMELQ | RGIKKPFTEV | IRANIGDAHA | MGQQPITFLR | QVMALCTYPN |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LLNSPSFPED | AKKRARRILQ | ACGGNSLGSY | SASQGVNCIR | EDVAAFITRR | DGVPADPDNI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| YLTTGASDGI | STILKLLVSG | GGKSRTGVMI | PIPQYPLYSA | VISELDAVQV | NYYLDEENCW |
| 250 | 260 | 270 | 280 | 290 | 300 |
| ALNVDELRRA | LRQAKDHCDP | KVLCIINPGN | PTGQVQSRKC | IEDVIHFAWE | EKLFLLADEV |
| 310 | 320 | 330 | 340 | 350 | 360 |
| YQDNVYSPDC | RFHSFKKVLY | QMGHEYSSNV | ELASFHSTSK | GYMGECGYRG | GYMEVINLHP |
| 370 | 380 | 390 | 400 | 410 | 420 |
| EIKGQLVKLL | SVRLCPPVSG | QAAMDIVVNP | PEPGEESFEQ | FSREKEFVLG | NLAKKAKLTE |
| 430 | 440 | 450 | 460 | 470 | 480 |
| DLFNQVPGIQ | CNPLQGAMYA | FPRILIPAKA | VEAAQSHKMA | PDMFYCMKLL | EETGICVVPG |
| 490 | 500 | 510 | 520 | ||
| SGFGQREGTY | HFRMTILPPV | DKLKTVLHKV | KDFHLKFLEQ | YS |